US Stock MarketDetailed Quotes

PHASQ PhaseBio Pharmaceuticals

Watchlist

0.000001
0.0000000.00%

15min DelayClose Apr 16 16:00 ET

49.86Market Cap0.00P/E (TTM)

PhaseBio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

(Q3)Sep 30, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.12%-10.41M

-124.35%-22.88M

20.92%-47.42M

-76.24%-19.99M

61.26%-6.13M

-23.80%-11.09M

57.19%-10.2M

-51.43%-59.96M

9.16%-11.35M

-92.08%-15.83M

Net income from continuing operations

41.89%-16.67M

59.28%-11.14M

-32.98%-131.07M

-41.93%-43.11M

-26.97%-31.92M

-1.91%-28.68M

-83.55%-27.36M

-151.14%-98.57M

-168.07%-30.38M

-120.73%-25.14M

Operating gains losses

-250.93%-8.72M

-607.22%-7.23M

69.36%21.18M

166.28%10.84M

-26.61%3.14M

55.80%5.78M

214.10%1.43M

--12.51M

--4.07M

--4.27M

Depreciation and amortization

3.43%603K

26.79%601K

252.95%1.79M

77.19%606K

136.36%130K

922.81%583K

777.78%474K

191.95%508K

584.00%342K

10.00%55K

Other non cash items

-65.85%4.09M

-71.58%3.38M

5.16%29.04M

-71.57%3.52M

-82.00%1.64M

125.87%11.99M

1,407.10%11.89M

5,423.60%27.62M

8,385.62%12.39M

9,033.00%9.13M

Change In working capital

743.47%9.56M

-436.93%-9.09M

789.07%29.37M

386.02%8M

524.11%20.16M

-115.58%-1.49M

125.23%2.7M

-74.53%-4.26M

192.62%1.65M

-289.40%-4.75M

-Change in receivables

----

--0

--18.4M

----

223.30%1.23M

--0

-Change in prepaid assets

-31.51%5.4M

-296.89%-1.9M

189.61%7.51M

232.32%1.88M

-2,264.43%-3.23M

216.23%7.89M

110.05%965K

-328.61%-8.38M

38.60%-1.42M

-93.69%149K

-Change in payables and accrued expense

784.33%4.37M

-508.20%-7.07M

340.76%12.69M

105.03%6.28M

208.55%5.32M

-110.38%-638K

221.54%1.73M

506.32%2.88M

167.42%3.06M

-989.56%-4.9M

-Change in other working capital

---208K

---117K

--9.17M

---158K

---335K

----

Cash from discontinued investing activities

Operating cash flow

6.12%-10.41M

-124.35%-22.88M

20.92%-47.42M

-76.24%-19.99M

61.26%-6.13M

-23.80%-11.09M

57.19%-10.2M

-51.43%-59.96M

9.16%-11.35M

-92.08%-15.83M

Investing cash flow

Cash flow from continuing investing activities

76.98%-58K

63.16%-49K

-89.73%-2.68M

-2,910.91%-1.66M

-258.43%-638K

51.63%-252K

79.79%-133K

-47.08%-1.41M

59.56%-55K

54.94%-178K

Net PPE purchase and sale

76.98%-58K

63.16%-49K

-104.19%-2.68M

-2,910.91%-1.66M

-258.43%-638K

51.63%-252K

76.16%-133K

-36.67%-1.31M

59.56%-55K

54.94%-178K

Net intangibles purchase and sale

----

--0

----

---100K

--0

Cash from discontinued investing activities

Investing cash flow

76.98%-58K

63.16%-49K

-89.73%-2.68M

-2,910.91%-1.66M

-258.43%-638K

51.63%-252K

79.79%-133K

-47.08%-1.41M

59.56%-55K

54.94%-178K

Financing cash flow

Cash flow from continuing financing activities

64.38%-415K

-100.30%-179K

312.34%63.77M

4,097.04%7.09M

-156.97%-1.33M

-138.03%-1.17M

497.66%59.17M

-71.11%15.47M

-96.54%169K

3,545.31%2.33M

Net issuance payments of debt

0.00%-1.36M

-100.04%-5.46M

-0.07%-1.36M

0.00%-1.36M

---1.36M

-138.13%-2.73M

-127.26%-1.36M

---1.36M

Net common stock issuance

497.30%735K

-98.04%1.19M

1,951.46%60.35M

--18K

-100.61%-15K

-139.19%-185K

--60.54M

-93.64%2.94M

--0

8,067.74%2.47M

Proceeds from stock option exercised by employees

-49.65%213K

--0

159.79%730K

6.69%255K

108.33%50K

42,200.00%423K

-88.24%2K

14.69%281K

895.83%239K

-74.74%24K

Net other financing activities

----

-45.60%8.14M

532.95%8.18M

--0

----

10,424.14%14.97M

--1.29M

--1.2M

Cash from discontinued financing activities

Financing cash flow

64.38%-415K

-100.30%-179K

312.34%63.77M

4,097.04%7.09M

-156.97%-1.33M

-138.03%-1.17M

497.66%59.17M

-71.11%15.47M

-96.54%169K

3,545.31%2.33M

Net cash flow

Beginning cash position

-75.72%18.69M

48.64%41.8M

-62.01%28.12M

43.21%56.36M

21.56%64.46M

29.48%76.96M

-62.01%28.12M

21.25%74.03M

-51.87%39.35M

-41.31%53.03M

Current changes in cash

12.98%-10.88M

-147.32%-23.11M

129.80%13.68M

-29.61%-14.56M

40.76%-8.1M

-94.93%-12.51M

434.89%48.84M

-453.81%-45.9M

-44.99%-11.23M

-59.51%-13.67M

End cash Position

-87.89%7.8M

-75.72%18.69M

48.64%41.8M

43.21%56.36M

21.56%64.46M

29.48%76.96M

-62.01%28.12M

-51.87%39.35M

Free cash flow

7.70%-10.47M

-121.94%-22.93M

18.37%-50.1M

-89.91%-21.65M

57.70%-6.77M

-19.65%-11.34M

57.80%-10.33M

-51.33%-61.37M

9.70%-11.4M

-85.35%-16.01M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020	(Q3)Sep 30, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.12%-10.41M	-124.35%-22.88M	20.92%-47.42M	-76.24%-19.99M	61.26%-6.13M	-23.80%-11.09M	57.19%-10.2M	-51.43%-59.96M	9.16%-11.35M	-92.08%-15.83M
Net income from continuing operations	41.89%-16.67M	59.28%-11.14M	-32.98%-131.07M	-41.93%-43.11M	-26.97%-31.92M	-1.91%-28.68M	-83.55%-27.36M	-151.14%-98.57M	-168.07%-30.38M	-120.73%-25.14M
Operating gains losses	-250.93%-8.72M	-607.22%-7.23M	69.36%21.18M	166.28%10.84M	-26.61%3.14M	55.80%5.78M	214.10%1.43M	--12.51M	--4.07M	--4.27M
Depreciation and amortization	3.43%603K	26.79%601K	252.95%1.79M	77.19%606K	136.36%130K	922.81%583K	777.78%474K	191.95%508K	584.00%342K	10.00%55K
Other non cash items	-65.85%4.09M	-71.58%3.38M	5.16%29.04M	-71.57%3.52M	-82.00%1.64M	125.87%11.99M	1,407.10%11.89M	5,423.60%27.62M	8,385.62%12.39M	9,033.00%9.13M
Change In working capital	743.47%9.56M	-436.93%-9.09M	789.07%29.37M	386.02%8M	524.11%20.16M	-115.58%-1.49M	125.23%2.7M	-74.53%-4.26M	192.62%1.65M	-289.40%-4.75M
-Change in receivables	----	----	--0	--0	--18.4M	----	----	223.30%1.23M	--0	--0
-Change in prepaid assets	-31.51%5.4M	-296.89%-1.9M	189.61%7.51M	232.32%1.88M	-2,264.43%-3.23M	216.23%7.89M	110.05%965K	-328.61%-8.38M	38.60%-1.42M	-93.69%149K
-Change in payables and accrued expense	784.33%4.37M	-508.20%-7.07M	340.76%12.69M	105.03%6.28M	208.55%5.32M	-110.38%-638K	221.54%1.73M	506.32%2.88M	167.42%3.06M	-989.56%-4.9M
-Change in other working capital	---208K	---117K	--9.17M	---158K	---335K	----	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	6.12%-10.41M	-124.35%-22.88M	20.92%-47.42M	-76.24%-19.99M	61.26%-6.13M	-23.80%-11.09M	57.19%-10.2M	-51.43%-59.96M	9.16%-11.35M	-92.08%-15.83M
Investing cash flow
Cash flow from continuing investing activities	76.98%-58K	63.16%-49K	-89.73%-2.68M	-2,910.91%-1.66M	-258.43%-638K	51.63%-252K	79.79%-133K	-47.08%-1.41M	59.56%-55K	54.94%-178K
Net PPE purchase and sale	76.98%-58K	63.16%-49K	-104.19%-2.68M	-2,910.91%-1.66M	-258.43%-638K	51.63%-252K	76.16%-133K	-36.67%-1.31M	59.56%-55K	54.94%-178K
Net intangibles purchase and sale	----	----	--0	--0	----	----	----	---100K	--0	--0
Cash from discontinued investing activities
Investing cash flow	76.98%-58K	63.16%-49K	-89.73%-2.68M	-2,910.91%-1.66M	-258.43%-638K	51.63%-252K	79.79%-133K	-47.08%-1.41M	59.56%-55K	54.94%-178K
Financing cash flow
Cash flow from continuing financing activities	64.38%-415K	-100.30%-179K	312.34%63.77M	4,097.04%7.09M	-156.97%-1.33M	-138.03%-1.17M	497.66%59.17M	-71.11%15.47M	-96.54%169K	3,545.31%2.33M
Net issuance payments of debt	0.00%-1.36M	0.00%-1.36M	-100.04%-5.46M	-0.07%-1.36M	0.00%-1.36M	---1.36M	---1.36M	-138.13%-2.73M	-127.26%-1.36M	---1.36M
Net common stock issuance	497.30%735K	-98.04%1.19M	1,951.46%60.35M	--18K	-100.61%-15K	-139.19%-185K	--60.54M	-93.64%2.94M	--0	8,067.74%2.47M
Proceeds from stock option exercised by employees	-49.65%213K	--0	159.79%730K	6.69%255K	108.33%50K	42,200.00%423K	-88.24%2K	14.69%281K	895.83%239K	-74.74%24K
Net other financing activities	----	----	-45.60%8.14M	532.95%8.18M	--0	----	----	10,424.14%14.97M	--1.29M	--1.2M
Cash from discontinued financing activities
Financing cash flow	64.38%-415K	-100.30%-179K	312.34%63.77M	4,097.04%7.09M	-156.97%-1.33M	-138.03%-1.17M	497.66%59.17M	-71.11%15.47M	-96.54%169K	3,545.31%2.33M
Net cash flow
Beginning cash position	-75.72%18.69M	48.64%41.8M	-62.01%28.12M	43.21%56.36M	21.56%64.46M	29.48%76.96M	-62.01%28.12M	21.25%74.03M	-51.87%39.35M	-41.31%53.03M
Current changes in cash	12.98%-10.88M	-147.32%-23.11M	129.80%13.68M	-29.61%-14.56M	40.76%-8.1M	-94.93%-12.51M	434.89%48.84M	-453.81%-45.9M	-44.99%-11.23M	-59.51%-13.67M
End cash Position	-87.89%7.8M	-75.72%18.69M	48.64%41.8M	48.64%41.8M	43.21%56.36M	21.56%64.46M	29.48%76.96M	-62.01%28.12M	-62.01%28.12M	-51.87%39.35M
Free cash flow	7.70%-10.47M	-121.94%-22.93M	18.37%-50.1M	-89.91%-21.65M	57.70%-6.77M	-19.65%-11.34M	57.80%-10.33M	-51.33%-61.37M	9.70%-11.4M	-85.35%-16.01M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall